Forty51 Ventures
Funding rounds backed by Forty51 Ventures.
- Funding disclosed in full
- $3.5M
- Median round
- $3.5M
- Rounds in calculation
- 1
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| Ferrosa Therapeutics Develops a bispecific antibody to treat anemia of inflammation | $3.5MSeed | BiotechSwitzerland | 1 participantForty51 Ventures |